Publications by authors named "Perry Chung"

Claim this Profile
C
Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax.
Lisa M Niswander, Perry Chung, Caroline Diorio, Sarah K Tasian

Haematologica· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Perry Chung

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
Emily M Hsieh, Regina M Myers, Bonnie Yates, Colleen Annesley, Samuel John, Perry Chung

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
Nicole J Wayne, Yimei Li, Perry Chung, Kristin Coffan, Susan R Rheingold

Pediatr Blood Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
Regina M Myers, Agne Taraseviciute, Seth M Steinberg, Adam J Lamble, Jennifer Sheppard, Perry Chung

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis